ArticleInternational journal of ophthalmology2025
Preliminary assessment of the safety and effectiveness of artificial iris implantation.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allogenic Corneal Iris Segment Implantation for Repair of Large Iris Defect: The Antep Procedure.Journal of current ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo preliminary explore the safety and effectiveness of artificial iris implantation.
methodsFourteen patients with iris defects who underwent artificial iris implantation at Hainan Boao Super Hospital from June 2020 to September 2021 were retrospectively analyzed for safety and effectiveness of the surgery by comparing the preoperative and postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), corneal endothelial cell density (ECD), ocular axial length (AL), anterior chamber depth (ACD), patient satisfaction of photophobia and appearance improvement, and postoperative complications.
resultsThe mean age was 37.21±14.85 (7-60)y, including 13 males and 1 female. The mean follow-up period was 4.64±2.32 (1-10)mo. The mean AL was 24.00±1.06 (21.68-25.58) mm. The postoperative mean anterior chamber depth measured was 4.07±0.75 (2.61-5.07) mm. The mean BCVA was 0.69±0.65 logMAR preoperatively and 0.46±0.60 logMAR at the last follow-up time (
conclusionThe novel artificial iris material is safe, which can significantly improve the appearance defects and photophobia, improve the postoperative visual acuity to a certain extent. This surgery had a high patient satisfaction rate with few and controllable postoperative complications. At the same time, the artificial iris, with its diverse configurations, variable colors, arbitrary cutting, and various surgical procedures, fully realizes personalized treatment, which solves the clinical problem of iris defect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.